Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules

by DeLong, Robert K, Reynolds, Christopher M, Malcolm, Yaneika, Schaeffer, Ashley, Severs, Tiffany, Wanekaya, Adam
Published 2010

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cel...

by Durie, Brian G M, Hoering, Antje, Abidi, Muneer H, Rajkumar, S Vincent, Epstein, Joshua, Kahanic, Stephen P, Thakuri, Mohan, Reu, Frederic, Reynolds, Christopher M, Sexton, Rachael, Orlowski, Robert Z, Barlogie, Bart, Dispenzieri, Angela
Published in Lancet (2016)

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously...

by Durie, Brian G. M., Hoering, Antje, Sexton, Rachael, Abidi, Muneer H., Epstein, Joshua, Rajkumar, S. Vincent, Dispenzieri, Angela, Kahanic, Stephen P., Thakuri, Mohan C., Reu, Frederic J., Reynolds, Christopher M., Orlowski, Robert Z., Barlogie, Bart
Published in Blood Cancer J (2020)